Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by LifeGoesOn1973on Feb 21, 2019 9:56am

105 Views

Post# 29393253

RE:RE:BCG supplies running short

Excellent article Enrique, confirms the numbers used in the company's presentation at page 7 regarding the 81 k new cases in the US and the 30% of the cases that become BCG non responsive. with the shortage in the BCG drug too and the non profitability Merck is experiencing then we would have a ready alternative to fill in the gap

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season